Kuwait Prediabetes Market Size & Outlook, 2025-2030

The prediabetes market in Kuwait is expected to reach a projected revenue of US$ 1.3 million by 2030. A compound annual growth rate of 7.7% is expected of Kuwait prediabetes market from 2025 to 2030.
Revenue, 2024 (US$M)
$0.8
Forecast, 2030 (US$M)
$1.3
CAGR, 2025 - 2030
7.7%
Report Coverage
Kuwait

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait prediabetes market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait prediabetes market highlights

  • The Kuwait prediabetes market generated a revenue of USD 0.8 million in 2024 and is expected to reach USD 1.3 million by 2030.
  • The Kuwait market is expected to grow at a CAGR of 7.7% from 2025 to 2030.
  • In terms of segment, diguanide was the largest revenue generating drug class in 2024.
  • Glucagon-like peptide-1 agonists (GLP-1) is the most lucrative drug class segment registering the fastest growth during the forecast period.


Prediabetes market data book summary

Market revenue in 2024USD 0.8 million
Market revenue in 2030USD 1.3 million
Growth rate7.7% (CAGR from 2025 to 2030)
Largest segmentDiguanide
Fastest growing segmentGlucagon-like peptide-1 agonists (GLP-1)
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDiguanide, Thiazolidinediones, Glucagon-like peptide-1 agonists (GLP-1), SGLT2 inhibitors, DPP-4 inhibitors
Key market players worldwideNovo Nordisk A/S ADR, Resverlogix Corp, AstraZeneca PLC, Bristol-Myers Squibb Co, Valbiotis, Caelus Health, SciMar, Boston Therapeutics, Aphaia


Other key industry trends

  • In terms of revenue, Kuwait accounted for 0.3% of the global prediabetes market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, Saudi Arabia prediabetes market is projected to lead the regional market in terms of revenue in 2030.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 1.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Prediabetes Market Companies

Name Profile # Employees HQ Website
Aphaia View profile 1-10 London, England, United Kingdom, Europe http://www.aphaia.co.uk
Boston Therapeutics View profile 11-50 Lawrence, Massachusetts, United States, North America http://www.bostonti.com
SciMar View profile 1-10 Dauphin, Manitoba, Canada, North America https://scimar.ca
Caelus Health View profile 1-10 Amsterdam, Noord-Holland, The Netherlands, Europe http://caelushealth.com/
Valbiotis View profile 11-50 La Rochelle, Poitou-Charentes, France, Europe http://valbiotis.com/
Resverlogix Corp View profile 18 4820 Richard Road South West, Suite 300, Calgary, AB, Canada, T3E 6L1 https://www.resverlogix.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Novo Nordisk A/S ADR View profile 66015 Novo Alle 1, Bagsvaerd, Denmark, 2880 https://www.novonordisk.com
Bristol-Myers Squibb Co View profile 34100 Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 https://www.bms.com

Kuwait prediabetes market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to prediabetes market will help companies and investors design strategic landscapes.


Diguanide was the largest segment with a revenue share of 87.5% in 2024. Horizon Databook has segmented the Kuwait prediabetes market based on diguanide, thiazolidinediones, glucagon-like peptide-1 agonists (glp-1), sglt2 inhibitors, dpp-4 inhibitors covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Kuwait prediabetes market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Kuwait prediabetes market databook

  • Our clientele includes a mix of prediabetes market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait prediabetes market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait prediabetes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Kuwait Age Group - Prediabetes Market size, 2024 - 2030 (US$M)

Kuwait Prediabetes Market Outlook Share, 2024 & 2030 (US$M)

Kuwait Age Group - Prediabetes Market size, 2024 - 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online